Clinical utility of sarcopenia dynamics assessed by psoas muscle volume in patients with colorectal cancer

被引:0
|
作者
Kumamoto, Tomotaka [1 ,2 ]
Takamizawa, Yasuyuki [1 ]
Miyake, Mototaka [3 ]
Inoue, Manabu [1 ]
Moritani, Konosuke [1 ]
Tsukamoto, Shunsuke [1 ]
Eto, Ken [2 ]
Kanemitsu, Yukihide [1 ]
机构
[1] Natl Canc Ctr, Dept Colorectal Surg, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan
[2] Jikei Univ, Sch Med, Dept Surg, Chuo Ku, Tokyo, Japan
[3] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo, Japan
关键词
colorectal cancer; psoas muscle volume; sarcopenia dynamics; SKELETAL-MUSCLE; MORTALITY; RESECTION; OUTCOMES; INDEX; MASS; COMPLICATIONS; PREVALENCE; IMPACT;
D O I
10.1002/wjs.12302
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundSarcopenia affects the postoperative prognosis of patients with colorectal cancer (CRC). Recently, it has become possible to measure psoas volume from computed tomography images, and an index called psoas volume index (PVI) has been reported. However, it is unclear whether the dynamics of PVI before and after surgery is associated with clinical outcomes after CRC surgery. This study aimed to evaluate the association between pre- and postoperative PVI dynamics and clinical outcomes after CRC surgery.MethodsThis study analyzed 1115 patients diagnosed with primary CRC and operated on for treatment between January 2014 and December 2017. Sarcopenia was defined as PVI below the lowest tertile in the preoperative assessment for each sex. The overall population was divided into four groups according to the dynamics of sarcopenia from preoperative to postoperative: group 1 (pre-to postoperative sarcopenia), group 2 (preoperative nonsarcopenia to postoperative sarcopenia), group 3 (pre-to postoperative nonsarcopenia), and group 4 (pre-to postoperative nonsarcopenia).ResultsBased on pre- and postoperative sarcopenia dynamics, 343 patients (29.7%) were classified into group 1, 105 patients (9.1%) into group 2, 42 patients (3.6%) into group 3, and 665 patients (57.6%) into group 4. Comparison of overall survival (OS) by the Kaplan-Meier method showed that Group 2 tended to have the worst prognosis (p = 0.007). Multivariate analysis showed an increased OS risk in Group 2 in sarcopenia dynamics (Hazard ratio: 2.103, 95% CI: 1.202-3.681, p = 0.009).ConclusionsSarcopenia dynamics using PVI is an independent prognostic predictor of OS in patients with CRC.
引用
收藏
页码:2098 / 2108
页数:11
相关论文
共 50 条
  • [11] Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery
    Marie Hanaoka
    Masamichi Yasuno
    Megumi Ishiguro
    Shinichi Yamauchi
    Akifumi Kikuchi
    Michiyo Tokura
    Toshiaki Ishikawa
    Eiji Nakatani
    Hiroyuki Uetake
    International Journal of Colorectal Disease, 2017, 32 : 847 - 856
  • [12] Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery
    Hanaoka, Marie
    Yasuno, Masamichi
    Ishiguro, Megumi
    Yamauchi, Shinichi
    Kikuchi, Akifumi
    Tokura, Michiyo
    Ishikawa, Toshiaki
    Nakatani, Eiji
    Uetake, Hiroyuki
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (06) : 847 - 856
  • [13] THE ASSOCIATION BETWEEN PROGNOSIS AND SARCOPENIA ASSESSED BY PSOAS MUSCLE MEASUREMENTS IN ELDERLY MALE PATIENTS WITH COVID-19
    Polat, Musa
    Salbas, Cigdem Samur
    Sari, Sema
    Dogan, Mustafa
    Cam, Selim
    Karadag, Ahmet
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2021, 24 (04): : 557 - 566
  • [14] Validity of measuring psoas muscle mass index for assessing sarcopenia in patients with gynecological cancer
    Yamada, Ryutaro
    Todo, Yukiharu
    Kurosu, Hiroyuki
    Minowa, Kaoru
    Tsuruta, Tomohiko
    Minobe, Shinichiro
    Matsumiya, Hiroko
    Kato, Hidenori
    Mori, Yoichi
    Osanai, Toshihisa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 393 - 399
  • [15] Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia
    Pigneur, Frederic
    Di Palma, Mario
    Raynard, Bruno
    Guibal, Aymeric
    Cohen, Frederic
    Daidj, Nassima
    Aziza, Richard
    El Hajjam, Mostafa
    Louis, Guillaume
    Goldwasser, Francois
    Deluche, Elise
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (04) : 1613 - 1620
  • [16] Clinical impact of sarcopenia for overweight or obese patients with colorectal cancer
    Chen, Wei-Zhe
    Lin, Feng
    Yu, Ding-Ye
    Ren, Qi
    Zhang, Feng-Min
    Shen, Zi-Le
    Chen, Wen-Hao
    Dong, Qian-Tong
    Yu, Zhen
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 23 - 30
  • [17] Psoas Muscle Volume as an Opportunistic Diagnostic Tool to Assess Sarcopenia in Patients with Hip Fractures: A Retrospective Cohort Study
    So, Sang-Pil
    Lee, Bum-Sik
    Kim, Ji-Wan
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [18] Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice
    Triarico, Silvia
    Rinninella, Emanuele
    Mele, Maria Cristina
    Cintoni, Marco
    Attina, Giorgio
    Ruggiero, Antonio
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2022, 76 (06) : 783 - 788
  • [19] Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice
    Silvia Triarico
    Emanuele Rinninella
    Maria Cristina Mele
    Marco Cintoni
    Giorgio Attinà
    Antonio Ruggiero
    European Journal of Clinical Nutrition, 2022, 76 : 783 - 788
  • [20] Clinical implication of preoperative psoas muscle area in endometrial cancer patients
    Bilir, Filiz
    Ozgul, Esra
    Elaziz, Burcin
    Arioz, Dagistan Tolga
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (12): : 1759 - 1763